|
GB1570494A
(en)
*
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
|
GB8912335D0
(en)
*
|
1989-05-30 |
1989-07-12 |
Smithkline Beckman Intercredit |
Compounds
|
|
US5280026A
(en)
*
|
1989-05-30 |
1994-01-18 |
Smithkline Beecham Intercredit B.V. |
Thienopyrimidines
|
|
US5098902A
(en)
*
|
1991-03-18 |
1992-03-24 |
Warner-Lambert Company |
Method of treating neurodegenerative diseases
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
US6608053B2
(en)
*
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
DE502006004066D1
(de)
*
|
2006-04-19 |
2009-08-06 |
Boehringer Ingelheim Pharma |
Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
|
|
EP1847543A1
(de)
|
2006-04-19 |
2007-10-24 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
|
|
CL2007001165A1
(es)
*
|
2006-04-26 |
2008-01-25 |
Hoffmann La Roche |
2-(1h-indazol-4-il)-6-(4-metanosulfonil-piperazin-1-ilmetil)-4-morfolin-4-il-tieno[3,2-d]pirimidina; procedimiento de preparacion; composicion farmaceutica; proceso de preparacion de dicha composicion; kit farmaceutico; y uso para tratar enfermedades tales como cancer, desordenes inmunes y enfermedades cardiovasculares.
|
|
PL2041139T3
(pl)
*
|
2006-04-26 |
2012-05-31 |
Hoffmann La Roche |
Związki farmaceutyczne
|
|
CL2007001166A1
(es)
|
2006-04-26 |
2008-01-25 |
Piramed Ltd |
Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica
|
|
BRPI0717907A2
(pt)
*
|
2006-12-07 |
2013-11-05 |
Genentech Inc |
"composto, composição farmacêutica, métodos para tratar um câncer, para inbir ou modular a atividade da lipídeo quinase, processo para a produçãoo de uma composição farmacêutica, uso de um composto e kit"
|
|
AR064155A1
(es)
*
|
2006-12-07 |
2009-03-18 |
Piramed Ltd |
Compuestos de inhibidores de fosfoinositido-3 quinasa y metodos de uso
|
|
EP2207781B1
(en)
|
2007-09-24 |
2012-11-28 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
|
JP5341899B2
(ja)
|
2007-10-19 |
2013-11-13 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ヘテロ環置換ピペラジノ−ジヒドロチエノピリミジン
|
|
ATE542825T1
(de)
*
|
2007-10-19 |
2012-02-15 |
Boehringer Ingelheim Int |
Substituierte piperidino-dihydrothienopyrimidine
|
|
JP5563466B2
(ja)
|
2007-10-19 |
2014-07-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ピペラジノ−ジヒドロチエノピリミジン誘導体
|
|
JP5348725B2
(ja)
|
2007-10-25 |
2013-11-20 |
ジェネンテック， インコーポレイテッド |
チエノピリミジン化合物の製造方法
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
CA2753285A1
(en)
|
2009-03-12 |
2010-09-16 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
|
|
SG182247A1
(en)
*
|
2009-05-27 |
2012-08-30 |
Hoffmann La Roche |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
SG175708A1
(en)
*
|
2009-05-27 |
2011-12-29 |
Genentech Inc |
Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
MX345155B
(es)
*
|
2009-10-12 |
2017-01-18 |
F Hoffmann-La Roche Ag * |
Combinaciones de un inhibidor de pi3k y un inhibidor de mek.
|
|
JP2013528787A
(ja)
|
2010-04-16 |
2013-07-11 |
ジェネンテック， インコーポレイテッド |
Ｐｉ３ｋ／ａｋｔキナーゼ経路インヒビターの効果の予測バイオマーカーとしてのｆｏｘ０３ａ
|
|
WO2012088254A1
(en)
|
2010-12-22 |
2012-06-28 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
|
US9802954B2
(en)
|
2011-08-24 |
2017-10-31 |
Boehringer Ingelheim International Gmbh |
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
|
|
US20130059866A1
(en)
|
2011-08-24 |
2013-03-07 |
Boehringer Ingelheim International Gmbh |
Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
|
|
BR112015020054A2
(pt)
|
2013-02-25 |
2017-08-29 |
Genentech Inc |
Método de detectar resistência aos efeitos terapêuticos de um inibidor de akt em uma célula cancerosa
|
|
US11098056B2
(en)
*
|
2018-10-01 |
2021-08-24 |
Genzyme Corporation |
UDP glycosyltransferase inhibitors and methods of use
|
|
GB202014736D0
(en)
*
|
2020-09-18 |
2020-11-04 |
Imperial College Innovations Ltd |
Novel compounds and their use in therapy
|